MOUNJARO

Description

This advanced research-grade dual agonist compound enables scientific investigation into the simultaneous modulation of both GIP and GLP-1 receptor pathways. It provides researchers with a tool to study how combined incretin receptor activation influences glucose metabolism, insulin sensitivity, and energy homeostasis in laboratory models, with particular relevance to diabetes and metabolic syndrome research.

Primary Laboratory Applications:

• Dual incretin receptor activation and signaling cascade research

• Glucose-dependent insulin secretion mechanism studies

• Insulin sensitivity and resistance pathway investigations

• Energy homeostasis and metabolic rate regulation research

• Comparative studies of single vs dual incretin receptor effects

Research Specifications:

• Molecular Weight: 4813.49 Da

• Purity: ≥99% by HPLC analysis

• Storage: Lyophilized at -20°C; reconstituted at 2-8°C

• Research Applications: Cell culture, receptor binding assays, metabolic models

• Documentation: Batch-specific Certificate of Analysis included